Abstract:Brief Introduction Cardiovascular disease is a leading cause of death, while the progression of the disease is closely related to the damaged endothelial cells (ECs) on the vessel wall. Regenerative medicine is now focused on the generation of functional cells to be used to replace those cells, in which induced pluripotent stem cells (iPSCs) have the great potential. iPSCs are an attractive option to derive new, fully functional ECs to regenerate damaged vasculature. Methods In this study we have generated iPSCs from human fibroblasts using viral induction of the four reprogramming transcription factors (OCT4, SOX2, KLF4, and c-MYC) or using a DNA-free integration method based on a single plasmid transfection and neomycin selection. iPSCs generated by plasmid transduction and selection was faster and provided a higher efficiency of colony formation. Colonies obtained using both methods were isolated, expanded and fully evaluated according to the standard criteria of iPSCs characterisation, including morphology, pluripotent marker expression, alkaline phosphatase staining, and teratoma formation. Results Human iPSCs were differentiated towards vascular cell lineages and specific to ECs. To this end, human iPSCs were seeded on collagen IV and cultured in the presence of Vascular Endothelial Growth Factor (VEGF). Time course experiments revealed the ability of iPSCs to differentiate into ECs and also revealed a greater potential to derive ECs from pluripotent cells generated by transient transfection. In an attempt to obtain a pure population of ECs, iPSCs cells were pre-differentiated into an early progenitor stage and CD34 selection was performed. The CD34+ cells were differentiated into ECs demonstrating a higher efficiency and led to greater homogeneity in derived ECs, expressing in high levels endothelial markers such as VE-Cadherin, PECAM1, KDR, eNOS, vWF. During iPSCs differentiation into ECs, the gene SETSIP (similar to SET protein) was found to be up-regulated. In order to define the mechanistic role of SETSIP, the protein was over-expressed and this markedly enhanced EC differentiation. Conversely, when SETSIP was knockdown by shRNA, EC differentiation was significantly suppressed. Importantly, immunofluorescence staining showed a nuclear translocation for SETSIP during EC differentiation and subsequent luciferase assays indicated that SETSIP and not SET protein induced VE-Cadherin transcriptional activation in the ECs. Conclusion In this study we have shown that CD34 positive cells derived from pre-differentiated human iPSCs have the potential to differentiate into ECs. SETSIP appears to have a critical role in this process though control of VE-Cadherin transcriptional activation. Ongoing studies that identify the key mechanisms controlling iPSC-derived EC-differentiation have considerable relevance for regeneration of damaged vasculature in a range of diseases.

Robust Differentiation of Human Pluripotent Stem Cells into Lymphatic Endothelial Cells Using Transcription Factors

Efficient Differentiation of Human Embryonic Stem Cells to Arterial and Venous Endothelial Cells under Feeder- and Serum-Free Conditions

Enhanced HSC-like Cell Generation from Mouse Pluripotent Stem Cells in a 3D Induction System Cocultured with Stromal Cells

Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method

Efficient Derivation of Lateral Plate and Paraxial Mesoderm Subtypes from Human Embryonic Stem Cells Through GSKi-Mediated Differentiation

Abstract 24044: Therapeutic Effects of human Pluripotent Stem Cell-derived Lymphatic Endothelial Cells encapsulated with Nanomatrix Gel on Experimental Lymphedema

Rapid Generation of Hpsc‐Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities

Functional Heterogeneity of Endothelial Cells Derived from Human Pluripotent Stem Cells

Conjugation of vascular endothelial growth factor to poly lactic-co-glycolic acid nanospheres enhances differentiation of embryonic stem cells to lymphatic endothelial cells

Cd34(+)Vegfr-3(+) Progenitor Cells Have A Potential to Differentiate Towards Lymphatic Endothelial Cells

Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells

Forward programming of hiPSCs via the transcription factor ETV2: rapid, reproducible, and cost-effective generation of highly enriched, functional endothelial cells

Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells

Functionality of Endothelial Cells and Pericytes from Human Pluripotent Stem Cells Demonstrated in Cultured Vascular Plexus and Zebrafish Xenografts.

The Differentiation of Pluripotent Stem Cells Towards Endothelial Progenitor Cells - Potential Application in Pulmonary Arterial Hypertension.

Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis

212 HUMAN INDUCED PLURIPOTENT STEM CELLS DIFFERENTIATE INTO PURE POPULATIONS OF ENDOTHELIAL CELLS MEDIATED BY SET SIMILAR PROTEIN THROUGH VE-CADHERIN TRANSCRIPTIONAL ACTIVATION

Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium

Single-Cell Transcriptome of Early Hematopoiesis Guides Arterial Endothelium-Promoted Functional T Cell Generation from Human Pluripotent Stem Cells

Generation, Expansion and Functional Analysis of Endothelial Cells and Pericytes Derived from Human Pluripotent Stem Cells

Biphasic Modulation of Insulin Signaling Enables Highly Efficient Hematopoietic Differentiation from Human Pluripotent Stem Cells.